Assignee
CORTENDO AB PUBL
US·3 granted patents·7 pending applications·18 citations·filing 2014–2018
Top patents by PatentIndex Score
10 records- 0192US9918984B2Methods and compositions for treating diabetes, metabolic syndrome and other conditionsCORTENDO AB PUBL·Filed 2016·Granted Mar 20, 2018·10 cites·2 claims
- 0291US10098877B2Methods and compositions for treating diabetes, metabolic syndrome and other conditionsCORTENDO AB PUBL·Filed 2018·Granted Oct 16, 2018·8 cites·3 claims
- 0360US2017266183A1Methods and compositions for the treatment of cushing's syndrome using 2s, 4r ketoconazoleCORTENDO AB (PUBL)·Filed 2017·Application pending·0 cites
- 0458US2018125841A1Ketoconazole enantiomer in humansCORTENDO AB PUBL·Filed 2018·Application pending·0 cites
- 0552US2016067243A1Ketoconazole enantiomer in humansCORTENDO AB PUBL·Filed 2015·Application pending·0 cites
- 0645US9725436B2Cytochrome P450 inhibitors and their method of useCORTENDO AB (PUBL)·Filed 2014·Granted Aug 8, 2017·0 cites·13 claims
- 0745US2016244436A1Novel functionalized 5-(phenoxymethyl)-1,3-dioxane analogs exhibiting cytochrome p450 inhibition and their method of useCORTENDO AB (PUBL)·Filed 2014·Application pending·0 cites
- 0844US2015353530A1Novel functionalized 4-(phenoxymethyl(-1,3-dioxolane analogs exhibiting cytochrome p450 inhibition and their method of useCORTENDO AB PUBL·Filed 2014·Application pending·0 cites
- 0932US2015337003A1Abiraterone and analogs thereof for the treatment of diseases associated with cortisol overproductionCORTENDO AB PUBL·Filed 2014·Application pending·0 cites
- 1031US2015210641A1Novel cytochrome p450 inhibitors and their method of useCORTENDO AB PUBL·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →